Supplemental material
Journal of Medical Economics
Volume 25, 2022 - Issue 1
Open access
1,800
Views
3
CrossRef citations to date
0
Altmetric
Neurology
Stick or twist? Cost-effectiveness of siponimod compared with continuing existing disease-modifying therapies in the treatment of active secondary progressive multiple sclerosis in the UK
S. Montgomerya Costello Medical Consulting Ltd, Cambridge, UKhttps://orcid.org/0000-0002-8481-5850
, F. Woodhousea Costello Medical Consulting Ltd, Cambridge, UKhttps://orcid.org/0000-0002-6958-840X
, U. Vudumulab Novartis Ireland Limited, Dublin, Irelandhttps://orcid.org/0000-0002-7407-4059
, K. Gudalac Novartis Healthcare Private Limited, Hyderabad, India
, M. Duddyd Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UKhttps://orcid.org/0000-0003-2393-8977
& M. Kroese Novartis Pharmaceuticals UK Ltd, London, UKCorrespondence[email protected]
Pages 669-678
|
Received 04 Apr 2022, Accepted 12 May 2022, Published online: 27 May 2022
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.